ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
Corporate Governance
ag真人平台官方:Disclosures
Stock Information
IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:Prospectus
ag真人平台官方:Announcements
2023.04.19
2022 AGM Circular
2023.04.19
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2023.04.19
ANNUAL REPORT 2022
2023.04.17
DATE OF BOARD MEETING
2023.04.04
VOLUNTARY ANNOUNCEMENT ENTERING INTO DISTRIBUTION AND SUPPLY AGREEMENT WITH CTTQ...
2023.03.30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
2023.03.28
VOLUNTARY ANNOUNCEMENT ENTERING INTO LICENSE AND DISTRIBUTION AGREEMENT WITH OEP...
2023.03.17
VOLUNTARY ANNOUNCEMENT “ENOXAPARIN SODIUM INJECTION” OBTAINED ANDA APPROVAL FROM...
2023.03.15
DATE OF BOARD MEETING
2023.02.24
Overseas Regulatory Announcement
第一页
上一页
4
5
6
7
8
下一页
最后一页
About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.